Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Non Operating Income (2021 - 2023)

Historic Other Non Operating Income for Cullinan Therapeutics (CGEM) over the last 3 years, with Q4 2023 value amounting to -$117000.0.

  • Cullinan Therapeutics' Other Non Operating Income fell 13926.17% to -$117000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $239000.0, marking a year-over-year increase of 31929.82%. This contributed to the annual value of -$199000.0 for FY2024, which is 18326.36% down from last year.
  • According to the latest figures from Q4 2023, Cullinan Therapeutics' Other Non Operating Income is -$117000.0, which was down 13926.17% from $180000.0 recorded in Q3 2023.
  • In the past 5 years, Cullinan Therapeutics' Other Non Operating Income ranged from a high of $298000.0 in Q4 2022 and a low of -$241000.0 during Q2 2022
  • Moreover, its 3-year median value for Other Non Operating Income was $1000.0 (2021), whereas its average is $28800.0.
  • The largest annual percentage gain for Cullinan Therapeutics' Other Non Operating Income in the last 5 years was 735000.0% (2022), contrasted with its biggest fall of 291250.0% (2022).
  • Cullinan Therapeutics' Other Non Operating Income (Quarter) stood at $4000.0 in 2021, then skyrocketed by 7350.0% to $298000.0 in 2022, then tumbled by 139.26% to -$117000.0 in 2023.
  • Its Other Non Operating Income stands at -$117000.0 for Q4 2023, versus $180000.0 for Q3 2023 and $69000.0 for Q2 2023.